Clinical Trial Update: RISE Adult Medication Study [Phase 3]

View source ↗

Summary

Phase 3 results for the RISE Adult Medication Study (RISE Study Group) have been completed and posted, involving prediabetes and type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prediabetes
• Type 2 Diabetes Mellitus

Snippet

Sponsor: RISE Study Group | Conditions: Prediabetes, Type 2 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2023-05-11